Bilateral acute anterior uveitis after alendronate
AR Malik, SH Campbell, NMG Toma - British journal of ophthalmology, 2002 - bjo.bmj.com
Biphosphonates are increasingly being used for the prevention and treatment of
osteoporosis in women where hormone replacement therapy is contraindicated. 1, 2 …
osteoporosis in women where hormone replacement therapy is contraindicated. 1, 2 …
Two case reports of zoledronic acid-induced uveitis
T Kennedy, PW Sellar, D Vaideanu-Collins… - Age and …, 2018 - academic.oup.com
Zoledronic acid (zoledronate) is a bisphosphonate used predominantly as a second-line
treatment for post-menopausal osteoporosis. Its administration is associated with an acute …
treatment for post-menopausal osteoporosis. Its administration is associated with an acute …
Zoledronic acid associated orbital inflammation.
LS Han, RG Weatherhead - Clinical & Experimental …, 2020 - search.ebscohost.com
A 59-year-old female patient had an intravenous zoledronic acid infusion (5 mg Aclasta;
Novartis New Zealand, Auckland, New Zealand) for the treatment of osteoporosis. The left …
Novartis New Zealand, Auckland, New Zealand) for the treatment of osteoporosis. The left …
Orbital myositis induced by alendronate: A case report
L Lefeuvre, A Caruso, E Biver… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Bisphosphonates are widely used, notably for osteoporosis
treatment. Their common side effects are well known. However, they can trigger less …
treatment. Their common side effects are well known. However, they can trigger less …
[引用][C] Pamidronate and uveitis
S De, P Meyer, AJ Crisp - Rheumatology, 1995 - academic.oup.com
Pamidronate and Uveltis SIR—We wish to report the case of a patient with polyostotic
Paget's disease of bone who developed severe acute anterior uveitis 24 h after completing …
Paget's disease of bone who developed severe acute anterior uveitis 24 h after completing …
Cutaneous side effects of antiosteoporosis treatments
P Musette, JM Kaufman, R Rizzoli… - Therapeutic …, 2011 - journals.sagepub.com
Cutaneous adverse reactions are reported for many therapeutic agents and, in general, are
observed in between 0% and 8% of treated patients depending on the drug …
observed in between 0% and 8% of treated patients depending on the drug …
Scleritis and other ocular side effects associated with pamidronate disodium
FW Fraunfelder, FT Fraunfelder, B Jensvold - American journal of …, 2003 - Elsevier
PURPOSE: To evaluate reported cases of scleritis and other ocular side effects associated
with pamidronate disodium, with emphasis on previously unreported cases of scleritis …
with pamidronate disodium, with emphasis on previously unreported cases of scleritis …
Ocular inflammation associated with alendronate therapy
JN Mbekeani, TL Slamovits, BH Schwartz… - Archives of …, 1999 - jamanetwork.com
old woman reported a 1-month history of right eye pain exacerbated by extraocular
movements. Progression to conjunctival hyperemia, horizontal diplopia, and upper eyelid …
movements. Progression to conjunctival hyperemia, horizontal diplopia, and upper eyelid …
Safety of long-term bisphosphonate therapy for the management of osteoporosis
EM Lewiecki - Drugs, 2011 - Springer
Drugs in the bisphosphonate class are the most commonly prescribed therapeutic agents for
the treatment of osteoporosis. Prospective, randomized, placebo-controlled clinical trials …
the treatment of osteoporosis. Prospective, randomized, placebo-controlled clinical trials …
Corneal graft rejection precipitated by uveitis secondary to alendronate sodium therapy
JC Richards, SJ Wiffen - Cornea, 2006 - journals.lww.com
Purpose: To report a case of corneal graft rejection precipitated by severe uveitis secondary
to alendronate therapy and to review the literature of relevance to this case. Methods: A 77 …
to alendronate therapy and to review the literature of relevance to this case. Methods: A 77 …